It has been demonstrated that the function of mammalian clock gene transcripts is controlled by the binding of
heme in vitro. To examine the effects of
heme on biological rhythms in vivo, we measured locomotor activity (LA) and core body temperature (T(b)) in a mouse model of
porphyria with impaired
heme biosynthesis by feeding mice a
griseofulvin (GF)-containing diet. Mice fed with a 2.0% GF-containing diet (GF2.0) transiently exhibited phase advance or phase advance-like phenomenon by 1-3 h in terms of the biological rhythms of T(b) or LA, respectively (both, P < 0.05) while mice were kept under conditions of a light/dark cycle (12 h:12 h). We also observed a transient, ~0.3 h shortening of the period of circadian T(b) rhythms in mice kept under conditions of constant darkness (P < 0.01). Interestingly, the observed duration of abnormal circadian rhythms in GF2.0 mice lasted between 1 and 3 wk after the onset of GF ingestion; this finding correlated well with the extent of impairment of
heme biosynthesis. When we examined the effects of therapeutic agents for
acute porphyria,
heme, and hypertonic
glucose on the pathological status of GF2.0 mice, it was found that the intraperitoneal administration of
heme (10 mg·kg(-1)·day(-1)) or
glucose (9 g·kg(-1)·day(-1)) for 7 days partially reversed (50%) increases in urinary δ-aminolevulinic
acids levels associated with
acute porphyria. Treatment with
heme, but not with
glucose, suppressed the phase advance (-like phenomenon) in the diurnal rhythms (P < 0.05) and restored the decrease of
heme (P < 0.01) in GF2.0 mice. These results suggest that impairments of
heme biosynthesis, in particular a decrease in
heme, may affect phase and period of circadian rhythms in animals.